Cargando…

Correction: MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells

Detalles Bibliográficos
Autores principales:	Beke, Lijs, Kig, Cenk, Linders, Joannes T. M., Boens, Shannah, Boeckx, An, van Heerde, Erika, Parade, Marc, De Bondt, An, Van den Wyngaert, Ilse, Bashir, Tarig, Ogata, Souichi, Meerpoel, Lieven, Van Eynde, Aleyde, Johnson, Christopher N., Beullens, Monique, Brehmer, Dirk, Bollen, Mathieu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Corrections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278382/ https://www.ncbi.nlm.nih.gov/pubmed/30504271 http://dx.doi.org/10.1042/BSR-20150194_COR

Ejemplares similares

MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2015)

Genome-wide promoter binding profiling of protein phosphatase-1 and its major nuclear targeting subunits
por: Verheyen, Toon, et al.
Publicado: (2015)

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
por: Joshi, Kaushal, et al.
Publicado: (2013)

MELK—a conserved kinase: functions, signaling, cancer, and controversy
por: Ganguly, Ranjit, et al.
Publicado: (2015)

The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets
por: Van Dessel, Nele, et al.
Publicado: (2010)

Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1
por: Verbinnen, Iris, et al.
Publicado: (2020)

The protein phosphatase 1 regulator NIPP1 is essential for mammalian spermatogenesis
por: Ferreira, Mónica, et al.
Publicado: (2017)

Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics()
por: Ferreira, Mónica, et al.
Publicado: (2019)

Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
por: Cigliano, Antonio, et al.
Publicado: (2019)

Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2016)

MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017)

p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017)

MELK is not necessary for the proliferation of basal-like breast cancer cells
por: Huang, Hai-Tsang, et al.
Publicado: (2017)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors
por: Meel, Michaël H, et al.
Publicado: (2020)

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
por: Pickard, Mark R, et al.
Publicado: (2009)

MELK expression correlates with tumor mitotic activity but is not required for cancer growth
por: Giuliano, Christopher J, et al.
Publicado: (2018)

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)

2193: Targeting MELK in acute lymphoblastic leukemia, new therapeutic approach
por: Alachkar, Houda, et al.
Publicado: (2018)

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
por: Laha, Dipranjan, et al.
Publicado: (2022)

A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells
por: Wang, Yubao, et al.
Publicado: (2018)

Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation
por: Nakano, Ichiro, et al.
Publicado: (2005)

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
por: Wang, Yubao, et al.
Publicado: (2014)

MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway
por: Xu, Qinyang, et al.
Publicado: (2020)

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
por: Tang, Qin, et al.
Publicado: (2020)

Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer
por: Hardeman, Ashley A., et al.
Publicado: (2022)

A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers
por: Zhou, Lin, et al.
Publicado: (2021)

Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
por: Chung, Suyoun, et al.
Publicado: (2012)

Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
por: Alachkar, Houda, et al.
Publicado: (2014)

Correction: MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
por: Wang, Yubao, et al.
Publicado: (2018)

Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis
por: Takeuchi, Hiroaki, et al.
Publicado: (2017)

Up-regulation of MELK by E2F1 promotes the proliferation in cervical cancer cells
por: Sun, Hongzhi, et al.
Publicado: (2021)

Ectopic expression of MELK in oral squamous cell carcinoma and its correlation with epithelial mesenchymal transition
por: Li, Bo, et al.
Publicado: (2021)

Computational exploration of maternal embryonic leucine zipper kinase (MELK) as a cancer drug target
por: Makki Almansour, Nahlah
Publicado: (2022)

siRNA-Mediated MELK Knockdown Induces Accelerated Wound Healing with Increased Collagen Deposition
por: Szymanski, Lukasz, et al.
Publicado: (2023)

AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma
por: Xu, Yunqing, et al.
Publicado: (2023)

Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
por: Kato, Taigo, et al.
Publicado: (2016)

Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK
por: Gong, Xianling, et al.
Publicado: (2018)

Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells
por: Li, Hongchun, et al.
Publicado: (2020)

MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function
por: Li, Zhipeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dgjvcv6gug62a4r64goqgu5l5i